“…IFITMs inhibit SARS‐CoV, 229E, and MERS‐CoV entry, but promote infection by HCoV‐OC43, a coronavirus that causes the common cold (Huang et al , 2011; Bertram et al , 2013; Warren et al , 2014; Wrensch et al , 2014; Zhao et al , 2014; Zhao et al , 2018). IFITMs, as well as other ISGs, including LY6E and Cholesterol 25‐hydrolase (CH25H), impair SARS‐CoV‐2 replication by blocking the fusion of virions (Pfaender et al , 2020; preprint: Zang et al , 2020; Zhao et al , 2020). Most of the experiments regarding these ISGs have been performed with single‐cycle viral pseudotypes.…”